UDP Glucuronosyltransferase Family 1 Member A Complex Locus (UGT1A) polymorphisms associated with worse outcome in colorectal cancer patients treated with irinotecan-based chemotherapy [38], indicated that UGT1A genetic variants might potentially be developed as a biomarker of drug resistance during cancer therapy. The gene discussed is UGT1A1; the disease is cancer.